SYRE
Spyre Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.40 / 10
Netural
Technical score is 3.4/10 (neutral). The Long Upper Shadow pattern shows modest bullish bias, but MACD Golden Cross and Marubozu White signal bearish pressure. Recent indicators are mixed, leaving the short‑term trend unclear and volatility high.
Analysis Checks(1/3)
Long Upper Shadow
Score6.54/10
Win Rate56.41%
Hist. Signals39
Avg Return1.16%
Score6.54/10
Win Rate56.41%
Hist. Signals39
Avg Return1.16%
Marubozu White
Score1/10
Win Rate35.71%
Hist. Signals14
Avg Return-1.09%
Score1/10
Win Rate35.71%
Hist. Signals14
Avg Return-1.09%
MACD Golden Cross
Score2.66/10
Win Rate37.50%
Hist. Signals8
Avg Return1.61%
Score2.66/10
Win Rate37.50%
Hist. Signals8
Avg Return1.61%
Long Upper Shadow
Score6.54/10
Win Rate56.41%
Hist. Signals39
Avg Return1.16%
Score6.54/10
Win Rate56.41%
Hist. Signals39
Avg Return1.16%
MACD Golden Cross
Score2.66/10
Win Rate37.50%
Hist. Signals8
Avg Return1.61%
Score2.66/10
Win Rate37.50%
Hist. Signals8
Avg Return1.61%
Marubozu White
Score1/10
Win Rate35.71%
Hist. Signals14
Avg Return-1.09%
Score1/10
Win Rate35.71%
Hist. Signals14
Avg Return-1.09%
Technical Analysis of SYRE?
- SYRE presents a Netural setup with a Technical Score of 3.40/10. Key technical indicators highlight an RSI of 60.73 and a MACD of 0.71, with the trend anchored by the 50-Day SMA at 39.64. Traders should monitor key support at 48.03 and resistance at 50.39.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
